HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/4/H1420    most recent 00167.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhang, J. Articles by Bache, R. J. Search for Related Content PubMed PubMed Citation Articles by Zhang, J. Articles by Bache, R. J.

Myocardial oxygenation and high-energy phosphate levels during K_ATP channel blockade

Departments of Medicine, Radiology, Physiology and the Center for Magnetic Resonance Research, University of Minnesota Health Sciences Center, Minneapolis, Minnesota 55455

Submitted 23 February 2003 ; accepted in final form 26 May 2003

Inhibition of ATP-sensitive K⁺ (K_ATP) channel activity has previously been demonstrated to result in coronary vasoconstriction with decreased myocardial blood flow and loss of phosphocreatine (PCr). This study was performed to determine whether the high-energy phosphate abnormality during K_ATP channel blockade can be ascribed to oxygen insufficiency. Myocardial blood flow and oxygen extraction were measured in open-chest dogs during K_ATP channel blockade with intracoronary glibenclamide, whereas high-energy phosphates were examined with ³¹P magnetic resonance spectroscopy (MRS), and myocardial deoxymyoglobin (Mb-) was determined with ¹H MRS. Glibenclamide resulted in a 20 ± 8% decrease of myocardial blood flow that was associated with a loss of phosphocreatine (PCr) and accumulation of inorganic phosphate. Mb- was undetectable during basal conditions but increased to 58 ± 5% of total myoglobin during glibenclamide administration. This degree of myoglobin desaturation during glibenclamide was far greater than we previously observed during a similar reduction of blood flow produced by a coronary stenosis (22% of myoglobin deoxygenated during stenosis). The findings suggest that reduction of coronary blood flow with an arterial stenosis was associated with a decrease of myocardial energy demands and that this response to hypoperfusion was inhibited by K_ATP channel blockade.

blood flow; myoglobin; oxygen saturation